BioAmber prices IPO at $10, the low end of the range

By
A A A

BioAmber, which converts renewable feedstocks into bio-succinic acid and other chemicals, raised $80 million by offering 8.0 million units at $10, the low end of the range of $10 to $12. The units consist of one common share and one warrant to purchase half a common share at $11 per whole common share. BioAmber plans to list the units on the NYSE under the symbol BIOAU, the common stock under the symbol BIOA and the warrants under the symbol BIOAWS. BioAmber also intends to list its common stock on the NYSE Euronext in Paris under the symbol BIOA. BioAmber initially filed confidentially on 11/9/2012. Credit Suisse, Societe Generale and Barclays acted as joint bookrunners on the deal.




The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: News Headlines , IPOs

Referenced Stocks: BIOAU

Renaissance Capital

Renaissance Capital

More from Renaissance Capital:

Related Videos

Stocks

Referenced

Most Active by Volume

33,484,533
  • $88.6633 ▼ 9.94%
30,050,071
  • $43.12 ▼ 7.19%
28,604,811
  • $15.265 ▲ 0.43%
27,730,393
  • $76.36 ▲ 0.16%
27,406,372
  • $116.90 ▲ 1.38%
24,962,930
  • $41.06 ▼ 0.32%
20,475,856
  • $3.405 ▲ 6.41%
16,604,086
  • $63.48 ▼ 10.58%
As of 1/29/2015, 11:02 AM


Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com